Memantine Hydrochloride Tablet, Coated
NDC Package 62332-075-91
Package Information
Memantine Hydrochloride tablets is memantine hydrochloride is indiacted for the treatment of moderate to severe dementia of the Alzheimer's type. This formulation utilizes a tablet, coated delivery system. Marketed by Alembic Pharmaceuticals Inc., this product is identified by NDC 62332-075 and is authorized under FDA application ANDA200891.
Identification & Billing
- RxCUI: 996561 - memantine HCl 10 MG Oral Tablet
- RxCUI: 996561 - memantine hydrochloride 10 MG Oral Tablet
- RxCUI: 996571 - memantine HCl 5 MG Oral Tablet
- RxCUI: 996571 - memantine hydrochloride 5 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 62332 - Alembic Pharmaceuticals Inc.
- 62332-075 - Memantine Hydrochloride
- 62332-075-91 - 1000 TABLET, COATED in 1 BOTTLE
- 62332-075 - Memantine Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (62332-075). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 62332-075-91 identifies a specific commercial package of 1000 tablet, coated in 1 bottle of Memantine Hydrochloride, a human prescription drug labeled by Alembic Pharmaceuticals Inc.. This tablet, coated is formulated for oral use and contains memantine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Alembic Pharmaceuticals Inc. on October 13, 2015. The current certification is valid through December 31, 2026.
How is this Alembic Pharmaceuticals Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 62332007591. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1000 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.